866-997-4948(US-Canada Toll Free)

United States OTC Drug Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 105 Pages

Notes:
Sales, means the sales volume of OTC Drug
Revenue, means the sales value of OTC Drug

This report studies sales (consumption) of OTC Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of OTC Drug in each application, can be divided into
Application 1
Application 2

Table of Contents

United States OTC Drug Market Report 2017
1 OTC Drug Overview
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of OTC Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of OTC Drug (2012-2022)
1.4.1 United States OTC Drug Sales and Growth Rate (2012-2022)
1.4.2 United States OTC Drug Revenue and Growth Rate (2012-2022)

2 United States OTC Drug Competition by Manufacturers
2.1 United States OTC Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States OTC Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States OTC Drug Average Price by Manufactures (2015 and 2016)
2.4 OTC Drug Market Competitive Situation and Trends
2.4.1 OTC Drug Market Concentration Rate
2.4.2 OTC Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States OTC Drug Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States OTC Drug Sales and Market Share by States (2012-2017)
3.2 United States OTC Drug Revenue and Market Share by States (2012-2017)
3.3 United States OTC Drug Price by States (2012-2017)

4 United States OTC Drug Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States OTC Drug Sales and Market Share by Type (2012-2017)
4.2 United States OTC Drug Revenue and Market Share by Type (2012-2017)
4.3 United States OTC Drug Price by Type (2012-2017)
4.4 United States OTC Drug Sales Growth Rate by Type (2012-2017)

5 United States OTC Drug Sales (Volume) by Application (2012-2017)
5.1 United States OTC Drug Sales and Market Share by Application (2012-2017)
5.2 United States OTC Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States OTC Drug Manufacturers Profiles/Analysis
6.1 Bayer HealthCare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 OTC Drug Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline (GSK)
6.2.2 OTC Drug Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson&Johnson
6.3.2 OTC Drug Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 OTC Drug Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 OTC Drug Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca
6.6.2 OTC Drug Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 BioGaia
6.7.2 OTC Drug Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol Myers Squibb
6.8.2 OTC Drug Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bukwang Pharmaceutica
6.9.2 OTC Drug Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Chr. Hansen
6.10.2 OTC Drug Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Cipla
6.12 CoLucid
6.13 Daiichi Sankyo
6.14 Friggs
6.15 DSM
6.16 Eisai
6.17 Eli Lilly
6.18 Herbalife
6.19 Euradite

7 OTC Drug Manufacturing Cost Analysis
7.1 OTC Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of OTC Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 OTC Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States OTC Drug Market Forecast (2017-2022)
11.1 United States OTC Drug Sales, Revenue Forecast (2017-2022)
11.2 United States OTC Drug Sales Forecast by Type (2017-2022)
11.3 United States OTC Drug Sales Forecast by Application (2017-2022)
11.4 OTC Drug Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of OTC Drug
Table Classification of OTC Drug
Figure United States Sales Market Share of OTC Drug by Type in 2015
Table Application of OTC Drug
Figure United States Sales Market Share of OTC Drug by Application in 2015
Figure United States OTC Drug Sales and Growth Rate (2012-2022)
Figure United States OTC Drug Revenue and Growth Rate (2012-2022)
Table United States OTC Drug Sales of Key Manufacturers (2015 and 2016)
Table United States OTC Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 OTC Drug Sales Share by Manufacturers
Figure 2016 OTC Drug Sales Share by Manufacturers
Table United States OTC Drug Revenue by Manufacturers (2015 and 2016)
Table United States OTC Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States OTC Drug Revenue Share by Manufacturers
Table 2016 United States OTC Drug Revenue Share by Manufacturers
Table United States Market OTC Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market OTC Drug Average Price of Key Manufacturers in 2015
Figure OTC Drug Market Share of Top 3 Manufacturers
Figure OTC Drug Market Share of Top 5 Manufacturers
Table United States OTC Drug Sales by States (2012-2017)
Table United States OTC Drug Sales Share by States (2012-2017)
Figure United States OTC Drug Sales Market Share by States in 2015
Table United States OTC Drug Revenue and Market Share by States (2012-2017)
Table United States OTC Drug Revenue Share by States (2012-2017)
Figure Revenue Market Share of OTC Drug by States (2012-2017)
Table United States OTC Drug Price by States (2012-2017)
Table United States OTC Drug Sales by Type (2012-2017)
Table United States OTC Drug Sales Share by Type (2012-2017)
Figure United States OTC Drug Sales Market Share by Type in 2015
Table United States OTC Drug Revenue and Market Share by Type (2012-2017)
Table United States OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Table United States OTC Drug Price by Type (2012-2017)
Figure United States OTC Drug Sales Growth Rate by Type (2012-2017)
Table United States OTC Drug Sales by Application (2012-2017)
Table United States OTC Drug Sales Market Share by Application (2012-2017)
Figure United States OTC Drug Sales Market Share by Application in 2015
Table United States OTC Drug Sales Growth Rate by Application (2012-2017)
Figure United States OTC Drug Sales Growth Rate by Application (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Market Share (2012-2017)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson OTC Drug Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer OTC Drug Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi OTC Drug Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca OTC Drug Sales Market Share (2012-2017)
Table BioGaia Basic Information List
Table BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table BioGaia OTC Drug Sales Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol Myers Squibb OTC Drug Sales Market Share (2012-2017)
Table Bukwang Pharmaceutica Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bukwang Pharmaceutica OTC Drug Sales Market Share (2012-2017)
Table Chr. Hansen Basic Information List
Table Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Chr. Hansen OTC Drug Sales Market Share (2012-2017)
Table Cipla Basic Information List
Table CoLucid Basic Information List
Table Daiichi Sankyo Basic Information List
Table Friggs Basic Information List
Table DSM Basic Information List
Table Eisai Basic Information List
Table Eli Lilly Basic Information List
Table Herbalife Basic Information List
Table Euradite Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure United States OTC Drug Production and Growth Rate Forecast (2017-2022)
Figure United States OTC Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States OTC Drug Production Forecast by Type (2017-2022)
Table United States OTC Drug Consumption Forecast by Application (2017-2022)
Table United States OTC Drug Sales Forecast by States (2017-2022)
Table United States OTC Drug Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *